6YF0
FKBP12 in complex with the BMP potentiator compound 9 at 1.55 A resolution
Summary for 6YF0
Entry DOI | 10.2210/pdb6yf0/pdb |
Descriptor | Peptidyl-prolyl cis-trans isomerase FKBP1A, 18-HYDROXYASCOMYCIN, SULFATE ION, ... (4 entities in total) |
Functional Keywords | immunosuppression, immunosuppressant, bmp enhancer program, isomerase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 12894.75 |
Authors | Kallen, J. (deposition date: 2020-03-25, release date: 2021-03-10, Last modification date: 2024-01-24) |
Primary citation | Larraufie, M.H.,Gao, X.,Xia, X.,Devine, P.J.,Kallen, J.,Liu, D.,Michaud, G.,Harsch, A.,Savage, N.,Ding, J.,Tan, K.,Mihalic, M.,Roggo, S.,Canham, S.M.,Bushell, S.M.,Krastel, P.,Gao, J.,Izaac, A.,Altinoglu, E.,Lustenberger, P.,Salcius, M.,Harbinski, F.,Williams, E.T.,Zeng, L.,Loureiro, J.,Cong, F.,Fryer, C.J.,Klickstein, L.,Tallarico, J.A.,Jain, R.K.,Rothman, D.M.,Wang, S. Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury. Cell Chem Biol, 28:1271-, 2021 Cited by PubMed: 33894161DOI: 10.1016/j.chembiol.2021.04.001 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.55 Å) |
Structure validation
Download full validation report